Home Economics GSK says sells thrombosis brands, French plant

GSK says sells thrombosis brands, French plant

Advertisement Disclosure: When you purchase through our sponsored links, we may earn a commission from our partners. By using this website you agree to our T&Cs.

GSK says sells thrombosis brands, French plant (via AFP)

British drugs firm GlaxoSmithKline (GSK) said Monday that it has sold two thrombosis brands and a French plant to South African peer Aspen for £700 million ($1.13 billion, 834 million euros). “GSK today announced it has reached agreement to sell its…

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

AFP
Editor

Related news

Consumer Price Index CPI

CPI Inflation Drops to 2.7% in November, Stocks Jump

Dave Kovaleski

Unemployment Rate Rises to Highest Level in 4 Years

Dave Kovaleski
Federal Reserve Rate Cuts

FOMC Lowers Rates for Third Straight Meeting

Dave Kovaleski

Fed and Earnings of World’s 6th Largest Firm on Tap This Week

Dave Kovaleski

Will September’s PCE Inflation Have Any Bearing on the Fed?

Dave Kovaleski

Must Read

New

How to Invest in Stocks in 2026 – Beginner’s Guide

Investing in stocks can be a great way to improve your overall wealth – but...

23 Min Read Read now

Latest News

Investing

Which Stocks Should You Buy, and Sell, in 2026?
Dave Kovaleski5 months

Also, the 3 sectors that Wall Street analysts are most bullish about. The usual suspects dominated in 2025 as both the Communication Services and Information Technology sectors helped boost the...